nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Nucleoside Analog—Abacavir—acquired immunodeficiency syndrome	0.184	0.21	CiPCiCtD
Valganciclovir—Nucleoside Analog—Didanosine—acquired immunodeficiency syndrome	0.184	0.21	CiPCiCtD
Valganciclovir—Nucleoside Analog—Stavudine—acquired immunodeficiency syndrome	0.184	0.21	CiPCiCtD
Valganciclovir—Nucleoside Analog—Zidovudine—acquired immunodeficiency syndrome	0.184	0.21	CiPCiCtD
Valganciclovir—Nucleoside Analog—Lamivudine—acquired immunodeficiency syndrome	0.14	0.159	CiPCiCtD
Valganciclovir—SLC6A14—digestive system—acquired immunodeficiency syndrome	0.00155	0.284	CbGeAlD
Valganciclovir—SLC6A14—lung—acquired immunodeficiency syndrome	0.00129	0.237	CbGeAlD
Valganciclovir—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000391	0.0716	CbGeAlD
Valganciclovir—SLC15A2—retina—acquired immunodeficiency syndrome	0.000348	0.0637	CbGeAlD
Valganciclovir—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000345	0.0632	CbGeAlD
Valganciclovir—SLC15A2—blood—acquired immunodeficiency syndrome	0.000233	0.0426	CbGeAlD
Valganciclovir—SLC15A2—spinal cord—acquired immunodeficiency syndrome	0.000224	0.0411	CbGeAlD
Valganciclovir—SLC15A2—vagina—acquired immunodeficiency syndrome	0.000216	0.0395	CbGeAlD
Valganciclovir—SLC15A2—lung—acquired immunodeficiency syndrome	0.000204	0.0374	CbGeAlD
Valganciclovir—SLC15A2—nervous system—acquired immunodeficiency syndrome	0.000189	0.0346	CbGeAlD
Valganciclovir—SLC15A2—central nervous system—acquired immunodeficiency syndrome	0.000182	0.0333	CbGeAlD
Valganciclovir—SLC15A2—brain—acquired immunodeficiency syndrome	0.000144	0.0264	CbGeAlD
Valganciclovir—SLC15A2—lymph node—acquired immunodeficiency syndrome	0.000139	0.0256	CbGeAlD
Valganciclovir—Convulsion—Ritonavir—acquired immunodeficiency syndrome	6.22e-05	0.000527	CcSEcCtD
Valganciclovir—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	6.21e-05	0.000526	CcSEcCtD
Valganciclovir—Vertigo—Saquinavir—acquired immunodeficiency syndrome	6.21e-05	0.000526	CcSEcCtD
Valganciclovir—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	6.21e-05	0.000526	CcSEcCtD
Valganciclovir—Hypertension—Ritonavir—acquired immunodeficiency syndrome	6.2e-05	0.000525	CcSEcCtD
Valganciclovir—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	6.19e-05	0.000524	CcSEcCtD
Valganciclovir—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	6.19e-05	0.000524	CcSEcCtD
Valganciclovir—Tremor—Lamivudine—acquired immunodeficiency syndrome	6.18e-05	0.000524	CcSEcCtD
Valganciclovir—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	6.17e-05	0.000523	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	6.17e-05	0.000522	CcSEcCtD
Valganciclovir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	6.16e-05	0.000522	CcSEcCtD
Valganciclovir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	6.16e-05	0.000522	CcSEcCtD
Valganciclovir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	6.15e-05	0.000521	CcSEcCtD
Valganciclovir—Pruritus—Stavudine—acquired immunodeficiency syndrome	6.14e-05	0.00052	CcSEcCtD
Valganciclovir—Asthenia—Abacavir—acquired immunodeficiency syndrome	6.13e-05	0.000519	CcSEcCtD
Valganciclovir—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	6.13e-05	0.000519	CcSEcCtD
Valganciclovir—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	6.12e-05	0.000518	CcSEcCtD
Valganciclovir—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	6.12e-05	0.000518	CcSEcCtD
Valganciclovir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	6.1e-05	0.000516	CcSEcCtD
Valganciclovir—Anaemia—Lamivudine—acquired immunodeficiency syndrome	6.1e-05	0.000516	CcSEcCtD
Valganciclovir—Anxiety—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.000516	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000515	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	6.06e-05	0.000513	CcSEcCtD
Valganciclovir—Pruritus—Abacavir—acquired immunodeficiency syndrome	6.05e-05	0.000512	CcSEcCtD
Valganciclovir—Fatigue—Indinavir—acquired immunodeficiency syndrome	6.05e-05	0.000512	CcSEcCtD
Valganciclovir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	6.04e-05	0.000512	CcSEcCtD
Valganciclovir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	6.04e-05	0.000512	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	6.04e-05	0.000511	CcSEcCtD
Valganciclovir—Cough—Saquinavir—acquired immunodeficiency syndrome	6.03e-05	0.000511	CcSEcCtD
Valganciclovir—Pain—Indinavir—acquired immunodeficiency syndrome	6e-05	0.000508	CcSEcCtD
Valganciclovir—Constipation—Indinavir—acquired immunodeficiency syndrome	6e-05	0.000508	CcSEcCtD
Valganciclovir—Insomnia—Efavirenz—acquired immunodeficiency syndrome	5.99e-05	0.000508	CcSEcCtD
Valganciclovir—Urticaria—Zidovudine—acquired immunodeficiency syndrome	5.99e-05	0.000507	CcSEcCtD
Valganciclovir—Convulsion—Saquinavir—acquired immunodeficiency syndrome	5.99e-05	0.000507	CcSEcCtD
Valganciclovir—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	5.98e-05	0.000507	CcSEcCtD
Valganciclovir—Hypertension—Saquinavir—acquired immunodeficiency syndrome	5.97e-05	0.000506	CcSEcCtD
Valganciclovir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	5.96e-05	0.000505	CcSEcCtD
Valganciclovir—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	5.96e-05	0.000505	CcSEcCtD
Valganciclovir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	5.96e-05	0.000504	CcSEcCtD
Valganciclovir—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	5.95e-05	0.000504	CcSEcCtD
Valganciclovir—Malaise—Lamivudine—acquired immunodeficiency syndrome	5.95e-05	0.000504	CcSEcCtD
Valganciclovir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	5.94e-05	0.000503	CcSEcCtD
Valganciclovir—Nausea—Didanosine—acquired immunodeficiency syndrome	5.94e-05	0.000503	CcSEcCtD
Valganciclovir—Vertigo—Lamivudine—acquired immunodeficiency syndrome	5.93e-05	0.000502	CcSEcCtD
Valganciclovir—Hypotension—Delavirdine—acquired immunodeficiency syndrome	5.92e-05	0.000502	CcSEcCtD
Valganciclovir—Confusional state—Ritonavir—acquired immunodeficiency syndrome	5.91e-05	0.000501	CcSEcCtD
Valganciclovir—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	5.91e-05	0.0005	CcSEcCtD
Valganciclovir—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	5.9e-05	0.0005	CcSEcCtD
Valganciclovir—Somnolence—Efavirenz—acquired immunodeficiency syndrome	5.89e-05	0.000499	CcSEcCtD
Valganciclovir—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	5.89e-05	0.000499	CcSEcCtD
Valganciclovir—Anxiety—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000497	CcSEcCtD
Valganciclovir—Oedema—Ritonavir—acquired immunodeficiency syndrome	5.86e-05	0.000497	CcSEcCtD
Valganciclovir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	5.85e-05	0.000495	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	5.85e-05	0.000495	CcSEcCtD
Valganciclovir—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	5.83e-05	0.000494	CcSEcCtD
Valganciclovir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	5.82e-05	0.000493	CcSEcCtD
Valganciclovir—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	5.78e-05	0.00049	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	5.78e-05	0.000489	CcSEcCtD
Valganciclovir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	5.76e-05	0.000488	CcSEcCtD
Valganciclovir—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	5.76e-05	0.000488	CcSEcCtD
Valganciclovir—Cough—Lamivudine—acquired immunodeficiency syndrome	5.76e-05	0.000488	CcSEcCtD
Valganciclovir—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	5.76e-05	0.000488	CcSEcCtD
Valganciclovir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	5.75e-05	0.000487	CcSEcCtD
Valganciclovir—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	5.74e-05	0.000486	CcSEcCtD
Valganciclovir—Dizziness—Stavudine—acquired immunodeficiency syndrome	5.74e-05	0.000486	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	5.74e-05	0.000486	CcSEcCtD
Valganciclovir—Insomnia—Delavirdine—acquired immunodeficiency syndrome	5.73e-05	0.000486	CcSEcCtD
Valganciclovir—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	5.72e-05	0.000485	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	5.72e-05	0.000485	CcSEcCtD
Valganciclovir—Convulsion—Lamivudine—acquired immunodeficiency syndrome	5.72e-05	0.000484	CcSEcCtD
Valganciclovir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	5.71e-05	0.000484	CcSEcCtD
Valganciclovir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	5.71e-05	0.000484	CcSEcCtD
Valganciclovir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	5.7e-05	0.000482	CcSEcCtD
Valganciclovir—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	5.69e-05	0.000482	CcSEcCtD
Valganciclovir—Confusional state—Saquinavir—acquired immunodeficiency syndrome	5.69e-05	0.000482	CcSEcCtD
Valganciclovir—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	5.67e-05	0.00048	CcSEcCtD
Valganciclovir—Constipation—Efavirenz—acquired immunodeficiency syndrome	5.67e-05	0.00048	CcSEcCtD
Valganciclovir—Pain—Efavirenz—acquired immunodeficiency syndrome	5.67e-05	0.00048	CcSEcCtD
Valganciclovir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	5.66e-05	0.00048	CcSEcCtD
Valganciclovir—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	5.65e-05	0.000479	CcSEcCtD
Valganciclovir—Dizziness—Abacavir—acquired immunodeficiency syndrome	5.65e-05	0.000479	CcSEcCtD
Valganciclovir—Oedema—Saquinavir—acquired immunodeficiency syndrome	5.64e-05	0.000478	CcSEcCtD
Valganciclovir—Somnolence—Delavirdine—acquired immunodeficiency syndrome	5.64e-05	0.000477	CcSEcCtD
Valganciclovir—Headache—Nevirapine—acquired immunodeficiency syndrome	5.63e-05	0.000477	CcSEcCtD
Valganciclovir—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	5.62e-05	0.000476	CcSEcCtD
Valganciclovir—Infection—Saquinavir—acquired immunodeficiency syndrome	5.61e-05	0.000475	CcSEcCtD
Valganciclovir—Anxiety—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000474	CcSEcCtD
Valganciclovir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	5.59e-05	0.000473	CcSEcCtD
Valganciclovir—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	5.58e-05	0.000473	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	5.58e-05	0.000472	CcSEcCtD
Valganciclovir—Urticaria—Indinavir—acquired immunodeficiency syndrome	5.57e-05	0.000472	CcSEcCtD
Valganciclovir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	5.55e-05	0.00047	CcSEcCtD
Valganciclovir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	5.54e-05	0.00047	CcSEcCtD
Valganciclovir—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	5.54e-05	0.00047	CcSEcCtD
Valganciclovir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	5.53e-05	0.000469	CcSEcCtD
Valganciclovir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	5.53e-05	0.000469	CcSEcCtD
Valganciclovir—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	5.53e-05	0.000468	CcSEcCtD
Valganciclovir—Vomiting—Stavudine—acquired immunodeficiency syndrome	5.52e-05	0.000467	CcSEcCtD
Valganciclovir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	5.51e-05	0.000467	CcSEcCtD
Valganciclovir—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	5.49e-05	0.000465	CcSEcCtD
Valganciclovir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	5.48e-05	0.000464	CcSEcCtD
Valganciclovir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	5.48e-05	0.000464	CcSEcCtD
Valganciclovir—Hypotension—Ritonavir—acquired immunodeficiency syndrome	5.48e-05	0.000464	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	5.47e-05	0.000464	CcSEcCtD
Valganciclovir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	5.47e-05	0.000463	CcSEcCtD
Valganciclovir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	5.47e-05	0.000463	CcSEcCtD
Valganciclovir—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	5.46e-05	0.000463	CcSEcCtD
Valganciclovir—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	5.46e-05	0.000462	CcSEcCtD
Valganciclovir—Headache—Nelfinavir—acquired immunodeficiency syndrome	5.45e-05	0.000462	CcSEcCtD
Valganciclovir—Headache—Stavudine—acquired immunodeficiency syndrome	5.44e-05	0.00046	CcSEcCtD
Valganciclovir—Vomiting—Abacavir—acquired immunodeficiency syndrome	5.43e-05	0.00046	CcSEcCtD
Valganciclovir—Confusional state—Lamivudine—acquired immunodeficiency syndrome	5.43e-05	0.00046	CcSEcCtD
Valganciclovir—Constipation—Delavirdine—acquired immunodeficiency syndrome	5.42e-05	0.000459	CcSEcCtD
Valganciclovir—Pain—Delavirdine—acquired immunodeficiency syndrome	5.42e-05	0.000459	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	5.42e-05	0.000459	CcSEcCtD
Valganciclovir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	5.41e-05	0.000458	CcSEcCtD
Valganciclovir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	5.38e-05	0.000456	CcSEcCtD
Valganciclovir—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000456	CcSEcCtD
Valganciclovir—Oedema—Lamivudine—acquired immunodeficiency syndrome	5.38e-05	0.000456	CcSEcCtD
Valganciclovir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	5.38e-05	0.000456	CcSEcCtD
Valganciclovir—Headache—Abacavir—acquired immunodeficiency syndrome	5.36e-05	0.000454	CcSEcCtD
Valganciclovir—Infection—Lamivudine—acquired immunodeficiency syndrome	5.35e-05	0.000453	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	5.34e-05	0.000452	CcSEcCtD
Valganciclovir—Nausea—Nevirapine—acquired immunodeficiency syndrome	5.34e-05	0.000452	CcSEcCtD
Valganciclovir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	5.34e-05	0.000452	CcSEcCtD
Valganciclovir—Insomnia—Ritonavir—acquired immunodeficiency syndrome	5.3e-05	0.000449	CcSEcCtD
Valganciclovir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	5.28e-05	0.000447	CcSEcCtD
Valganciclovir—Hypotension—Saquinavir—acquired immunodeficiency syndrome	5.27e-05	0.000447	CcSEcCtD
Valganciclovir—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	5.27e-05	0.000447	CcSEcCtD
Valganciclovir—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	5.27e-05	0.000446	CcSEcCtD
Valganciclovir—Urticaria—Efavirenz—acquired immunodeficiency syndrome	5.26e-05	0.000446	CcSEcCtD
Valganciclovir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	5.24e-05	0.000444	CcSEcCtD
Valganciclovir—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	5.24e-05	0.000444	CcSEcCtD
Valganciclovir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	5.23e-05	0.000443	CcSEcCtD
Valganciclovir—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	5.23e-05	0.000443	CcSEcCtD
Valganciclovir—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.000443	CcSEcCtD
Valganciclovir—Somnolence—Ritonavir—acquired immunodeficiency syndrome	5.21e-05	0.000442	CcSEcCtD
Valganciclovir—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	5.2e-05	0.000441	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	5.18e-05	0.000439	CcSEcCtD
Valganciclovir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	5.17e-05	0.000438	CcSEcCtD
Valganciclovir—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	5.17e-05	0.000438	CcSEcCtD
Valganciclovir—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	5.16e-05	0.000437	CcSEcCtD
Valganciclovir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.16e-05	0.000437	CcSEcCtD
Valganciclovir—Nausea—Stavudine—acquired immunodeficiency syndrome	5.15e-05	0.000437	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.14e-05	0.000436	CcSEcCtD
Valganciclovir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.13e-05	0.000435	CcSEcCtD
Valganciclovir—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.1e-05	0.000432	CcSEcCtD
Valganciclovir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.1e-05	0.000432	CcSEcCtD
Valganciclovir—Nausea—Abacavir—acquired immunodeficiency syndrome	5.08e-05	0.00043	CcSEcCtD
Valganciclovir—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.07e-05	0.000429	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.06e-05	0.000429	CcSEcCtD
Valganciclovir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.06e-05	0.000428	CcSEcCtD
Valganciclovir—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.04e-05	0.000427	CcSEcCtD
Valganciclovir—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.03e-05	0.000426	CcSEcCtD
Valganciclovir—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.03e-05	0.000426	CcSEcCtD
Valganciclovir—Hypotension—Lamivudine—acquired immunodeficiency syndrome	5.03e-05	0.000426	CcSEcCtD
Valganciclovir—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.02e-05	0.000425	CcSEcCtD
Valganciclovir—Pain—Ritonavir—acquired immunodeficiency syndrome	5.01e-05	0.000425	CcSEcCtD
Valganciclovir—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.01e-05	0.000425	CcSEcCtD
Valganciclovir—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.01e-05	0.000425	CcSEcCtD
Valganciclovir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.01e-05	0.000425	CcSEcCtD
Valganciclovir—Dizziness—Zidovudine—acquired immunodeficiency syndrome	4.99e-05	0.000422	CcSEcCtD
Valganciclovir—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	4.97e-05	0.000421	CcSEcCtD
Valganciclovir—Pruritus—Indinavir—acquired immunodeficiency syndrome	4.96e-05	0.00042	CcSEcCtD
Valganciclovir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.91e-05	0.000416	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.91e-05	0.000415	CcSEcCtD
Valganciclovir—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	4.88e-05	0.000414	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	4.87e-05	0.000413	CcSEcCtD
Valganciclovir—Insomnia—Lamivudine—acquired immunodeficiency syndrome	4.87e-05	0.000412	CcSEcCtD
Valganciclovir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	4.87e-05	0.000412	CcSEcCtD
Valganciclovir—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.83e-05	0.000409	CcSEcCtD
Valganciclovir—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	4.83e-05	0.000409	CcSEcCtD
Valganciclovir—Constipation—Saquinavir—acquired immunodeficiency syndrome	4.83e-05	0.000409	CcSEcCtD
Valganciclovir—Pain—Saquinavir—acquired immunodeficiency syndrome	4.83e-05	0.000409	CcSEcCtD
Valganciclovir—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	4.8e-05	0.000407	CcSEcCtD
Valganciclovir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.8e-05	0.000406	CcSEcCtD
Valganciclovir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.8e-05	0.000406	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.79e-05	0.000406	CcSEcCtD
Valganciclovir—Somnolence—Lamivudine—acquired immunodeficiency syndrome	4.79e-05	0.000405	CcSEcCtD
Valganciclovir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	4.75e-05	0.000403	CcSEcCtD
Valganciclovir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	4.75e-05	0.000402	CcSEcCtD
Valganciclovir—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	4.74e-05	0.000401	CcSEcCtD
Valganciclovir—Headache—Zidovudine—acquired immunodeficiency syndrome	4.72e-05	0.0004	CcSEcCtD
Valganciclovir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	4.69e-05	0.000397	CcSEcCtD
Valganciclovir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	4.68e-05	0.000396	CcSEcCtD
Valganciclovir—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	4.67e-05	0.000396	CcSEcCtD
Valganciclovir—Urticaria—Ritonavir—acquired immunodeficiency syndrome	4.66e-05	0.000395	CcSEcCtD
Valganciclovir—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	4.65e-05	0.000394	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	4.65e-05	0.000394	CcSEcCtD
Valganciclovir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	4.64e-05	0.000393	CcSEcCtD
Valganciclovir—Dizziness—Indinavir—acquired immunodeficiency syndrome	4.64e-05	0.000393	CcSEcCtD
Valganciclovir—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	4.64e-05	0.000393	CcSEcCtD
Valganciclovir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	4.64e-05	0.000393	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	4.61e-05	0.000391	CcSEcCtD
Valganciclovir—Constipation—Lamivudine—acquired immunodeficiency syndrome	4.6e-05	0.00039	CcSEcCtD
Valganciclovir—Pain—Lamivudine—acquired immunodeficiency syndrome	4.6e-05	0.00039	CcSEcCtD
Valganciclovir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	4.55e-05	0.000385	CcSEcCtD
Valganciclovir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	4.53e-05	0.000384	CcSEcCtD
Valganciclovir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	4.49e-05	0.00038	CcSEcCtD
Valganciclovir—Urticaria—Saquinavir—acquired immunodeficiency syndrome	4.48e-05	0.00038	CcSEcCtD
Valganciclovir—Nausea—Zidovudine—acquired immunodeficiency syndrome	4.48e-05	0.000379	CcSEcCtD
Valganciclovir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	4.46e-05	0.000378	CcSEcCtD
Valganciclovir—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	4.46e-05	0.000378	CcSEcCtD
Valganciclovir—Vomiting—Indinavir—acquired immunodeficiency syndrome	4.46e-05	0.000378	CcSEcCtD
Valganciclovir—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000376	CcSEcCtD
Valganciclovir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	4.42e-05	0.000374	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	4.4e-05	0.000373	CcSEcCtD
Valganciclovir—Headache—Indinavir—acquired immunodeficiency syndrome	4.39e-05	0.000372	CcSEcCtD
Valganciclovir—Dizziness—Efavirenz—acquired immunodeficiency syndrome	4.38e-05	0.000371	CcSEcCtD
Valganciclovir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	4.34e-05	0.000367	CcSEcCtD
Valganciclovir—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	4.32e-05	0.000366	CcSEcCtD
Valganciclovir—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.28e-05	0.000362	CcSEcCtD
Valganciclovir—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.26e-05	0.000361	CcSEcCtD
Valganciclovir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.26e-05	0.000361	CcSEcCtD
Valganciclovir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.21e-05	0.000357	CcSEcCtD
Valganciclovir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.21e-05	0.000356	CcSEcCtD
Valganciclovir—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.19e-05	0.000355	CcSEcCtD
Valganciclovir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.17e-05	0.000354	CcSEcCtD
Valganciclovir—Nausea—Indinavir—acquired immunodeficiency syndrome	4.17e-05	0.000353	CcSEcCtD
Valganciclovir—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.16e-05	0.000352	CcSEcCtD
Valganciclovir—Headache—Efavirenz—acquired immunodeficiency syndrome	4.15e-05	0.000352	CcSEcCtD
Valganciclovir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.15e-05	0.000351	CcSEcCtD
Valganciclovir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.05e-05	0.000343	CcSEcCtD
Valganciclovir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.03e-05	0.000341	CcSEcCtD
Valganciclovir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.01e-05	0.00034	CcSEcCtD
Valganciclovir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	3.99e-05	0.000338	CcSEcCtD
Valganciclovir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	3.99e-05	0.000338	CcSEcCtD
Valganciclovir—Headache—Delavirdine—acquired immunodeficiency syndrome	3.97e-05	0.000336	CcSEcCtD
Valganciclovir—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	3.97e-05	0.000336	CcSEcCtD
Valganciclovir—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.94e-05	0.000333	CcSEcCtD
Valganciclovir—Dizziness—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000328	CcSEcCtD
Valganciclovir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.86e-05	0.000327	CcSEcCtD
Valganciclovir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.86e-05	0.000327	CcSEcCtD
Valganciclovir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	3.81e-05	0.000323	CcSEcCtD
Valganciclovir—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.77e-05	0.000319	CcSEcCtD
Valganciclovir—Dizziness—Saquinavir—acquired immunodeficiency syndrome	3.73e-05	0.000316	CcSEcCtD
Valganciclovir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.73e-05	0.000316	CcSEcCtD
Valganciclovir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.69e-05	0.000313	CcSEcCtD
Valganciclovir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.68e-05	0.000312	CcSEcCtD
Valganciclovir—Headache—Ritonavir—acquired immunodeficiency syndrome	3.67e-05	0.000311	CcSEcCtD
Valganciclovir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.59e-05	0.000304	CcSEcCtD
Valganciclovir—Dizziness—Lamivudine—acquired immunodeficiency syndrome	3.56e-05	0.000302	CcSEcCtD
Valganciclovir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	3.56e-05	0.000301	CcSEcCtD
Valganciclovir—Headache—Saquinavir—acquired immunodeficiency syndrome	3.54e-05	0.000299	CcSEcCtD
Valganciclovir—Nausea—Ritonavir—acquired immunodeficiency syndrome	3.48e-05	0.000295	CcSEcCtD
Valganciclovir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.42e-05	0.00029	CcSEcCtD
Valganciclovir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.39e-05	0.000287	CcSEcCtD
Valganciclovir—Headache—Lamivudine—acquired immunodeficiency syndrome	3.37e-05	0.000286	CcSEcCtD
Valganciclovir—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.35e-05	0.000284	CcSEcCtD
Valganciclovir—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.2e-05	0.000271	CcSEcCtD
